Established in 1970, Candela is a leading US-based global medical aesthetic device company with headquarters in Marlborough, Massachusetts. The company’s technologies enable physicians to provide advanced energy-based solutions for a broad range of medical-aesthetic applications including treatment of benign vascular and pigmented lesions, scar revision, facial resurfacing, wrinkle reduction, acne, spider veins, cellulite reduction, body shaping, gynecological conditions, and tattoo and hair removal.

The company markets, services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.